🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/06/2007 18,42 18,60 18,00 18,42 +0,66% 3,26% 76.333
31/05/2007 18,24 18,42 17,82 18,30 +0,66% 3,29% 45.050
30/05/2007 17,94 18,48 17,88 18,18 +0,33% 3,34% 64.767
29/05/2007 17,64 18,48 17,22 18,12 +2,03% 7,14% 113.583
25/05/2007 17,64 17,94 17,10 17,76 +1,02% 4,76% 62.217
24/05/2007 17,70 17,82 17,10 17,58 -1,01% 4,07% 55.517
23/05/2007 18,00 18,12 17,28 17,76 -2,31% 4,67% 91.367
22/05/2007 17,64 18,30 17,04 18,18 +3,77% 7,14% 94.517
21/05/2007 17,22 17,94 17,10 17,52 +2,46% 4,88% 68.433
18/05/2007 16,68 17,10 16,56 17,10 +2,15% 3,24% 62.967
17/05/2007 16,86 16,86 16,20 16,74 -0,71% 3,91% 49.350
16/05/2007 16,50 16,86 16,08 16,86 +4,85% 4,73% 94.067
15/05/2007 16,62 16,86 16,02 16,08 -4,29% 5,05% 92.133
14/05/2007 17,22 17,22 16,50 16,80 -3,45% 4,18% 73.383
11/05/2007 16,14 17,40 15,36 17,40 +9,43% 12,64% 106.867
10/05/2007 16,68 16,80 15,78 15,90 -5,36% 6,12% 105.467
09/05/2007 17,64 17,64 16,68 16,80 -2,78% 5,44% 122.800
08/05/2007 18,24 18,24 16,86 17,28 -5,26% 7,57% 150.017
07/05/2007 19,56 19,56 18,06 18,24 +9,75% 7,67% 514.750
04/05/2007 16,56 16,74 16,38 16,62 +0,36% 2,17% 50.267
03/05/2007 16,44 16,56 15,84 16,56 +0,73% 4,38% 59.667
02/05/2007 16,20 16,62 16,20 16,44 +3,79% 2,59% 50.633
01/05/2007 16,56 16,62 15,66 15,84 -1,12% 5,80% 57.450
30/04/2007 16,68 16,80 15,84 16,02 -4,98% 5,76% 65.050
27/04/2007 16,44 16,98 16,14 16,86 +2,18% 5,11% 82.983
26/04/2007 16,74 16,80 16,32 16,50 -1,79% 2,87% 35.717
25/04/2007 16,56 16,80 16,38 16,80 +2,19% 2,54% 51.150
24/04/2007 16,50 16,92 16,14 16,44 -0,72% 4,73% 79.317
23/04/2007 17,16 17,40 16,44 16,56 -2,82% 5,59% 122.250
20/04/2007 18,18 18,30 16,86 17,04 -5,02% 7,92% 79.000